These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1038 related articles for article (PubMed ID: 19451443)

  • 41. Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.
    Uematsu T; Kasami M; Yuen S
    Breast Cancer; 2009; 16(2):97-104. PubMed ID: 18663562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PET/CT for therapy response assessment in lymphoma.
    Hutchings M; Barrington SF
    J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer.
    Chung MK; Jeong HS; Park SG; Jang JY; Son YI; Choi JY; Hyun SH; Park K; Ahn MJ; Ahn YC; Kim HJ; Ko YH; Baek CH
    Clin Cancer Res; 2009 Sep; 15(18):5861-8. PubMed ID: 19737951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
    Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G
    Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.
    Botteri E; Sandri MT; Bagnardi V; Munzone E; Zorzino L; Rotmensz N; Casadio C; Cassatella MC; Esposito A; Curigliano G; Salvatici M; Verri E; Adamoli L; Goldhirsch A; Nolè F
    Breast Cancer Res Treat; 2010 Jul; 122(1):211-7. PubMed ID: 19967556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.
    Iagaru A; Chawla S; Menendez L; Conti PS
    Nucl Med Commun; 2006 Oct; 27(10):795-802. PubMed ID: 16969262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study.
    Nguyen NC; Tran I; Hueser CN; Oliver D; Farghaly HR; Osman MM
    Clin Nucl Med; 2009 Dec; 34(12):886-90. PubMed ID: 20139823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The usefulness of whole body FDG-PET/CT in patients with brain metastasis].
    Nakagawa K; Aoyagi M; Inaji M; Maehara T; Toriyama H; Kawano Y; Tamaki M; Nariai T; Ohno K
    No Shinkei Geka; 2009 Feb; 37(2):159-66. PubMed ID: 19227157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of 18F-FDG PET/CT in management of high-grade salivary gland malignancies.
    Jeong HS; Chung MK; Son YI; Choi JY; Kim HJ; Ko YH; Baek CH
    J Nucl Med; 2007 Aug; 48(8):1237-44. PubMed ID: 17631549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The role of / 18FDG PET/CT for the initial staging and therapy in primary breast cancer].
    Inokuchi M; Furukawa H; Kayahara M; Ohta T; Kawashima H; Taki J; Kinuya S
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2526-31. PubMed ID: 20009451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
    D'souza MM; Sharma R; Mondal A; Jaimini A; Tripathi M; Saw SK; Singh D; Mishra A; Tripathi RP
    Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.
    Kim SY; Roh JL; Kim MR; Kim JS; Choi SH; Nam SY; Lee SW; Kim SB
    J Nucl Med; 2007 May; 48(5):752-7. PubMed ID: 17475963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
    Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
    Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monitoring of early response to neoadjuvant chemotherapy in breast cancer with (1)H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography.
    Tozaki M; Sakamoto M; Oyama Y; O'uchi T; Kawano N; Suzuki T; Yamashiro N; Ozaki S; Sakamoto N; Higa K; Abe S; Ogawa T; Fukuma E
    J Magn Reson Imaging; 2008 Aug; 28(2):420-7. PubMed ID: 18666159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of delayed enhanced CT and 18F-FDG PET/CT in the evaluation of adrenal masses in oncology patients.
    Park BK; Kim CK; Kim B; Choi JY
    J Comput Assist Tomogr; 2007; 31(4):550-6. PubMed ID: 17882030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing tumor response to therapy.
    Weber WA
    J Nucl Med; 2009 May; 50 Suppl 1():1S-10S. PubMed ID: 19380403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients.
    Giordano A; Giuliano M; De Laurentiis M; Eleuteri A; Iorio F; Tagliaferri R; Hortobagyi GN; Pusztai L; De Placido S; Hess K; Cristofanilli M; Reuben JM
    Breast Cancer Res Treat; 2011 Sep; 129(2):451-8. PubMed ID: 21710134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of fluorodeoxyglucose-PET versus fluorodeoxyglucose-PET/computed tomography in detection of unknown primary tumor: a meta-analysis of the literature.
    Dong MJ; Zhao K; Lin XT; Zhao J; Ruan LX; Liu ZF
    Nucl Med Commun; 2008 Sep; 29(9):791-802. PubMed ID: 18677207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.